Înapoi la știri

OpenAI contestă acuzațiile din procesul de secret comercial intentat de Apple

16 Jul 2026
1 minut min
Andrei Miroslavescu

👉 OpenAI răspunde acuzațiilor privind procesul de secret comercial

OpenAI a reacționat marți la acuzațiile aduse de Apple într-un proces privind secrete comerciale, sugerând că plângerea nu are temei. Potrivit techcrunch.com, compania a declarat că nu este conștientă de niciun fel de dovezi care să susțină plângerea.

👉 Declarația oficială a OpenAI privind competiția și inovația

„Deși luăm în serios aceste acuzații, nu suntem conștienți de nicio dovadă că această plângere are temei”, a afirmat OpenAI într-un comunicat, împărtășit inițial de reporterul Bloomberg, Ed Ludlow, pe platforma X. „Credem în competiția corectă și în libertatea oamenilor de a lucra unde aleg, iar noi ne concentrăm pe construirea de tehnologie inovatoare care împuternicește oamenii din întreaga lume.”

Publicitate
Alte postari din Economie
Economie

Millions tap to pay every day. Here's what scammers hope you'll miss - USA Today

Hide Caption #videoDetailsToggle{color:var( --color-dove-gray,rgba(0,0,0,.6));cursor:pointer;display:inline-block;font-family:var(--sans-serif,sans-serif);font-size:var(--type-7);font-weight:var( --font-weight-bold,900);line-height:var(--spacer-twentyfour,24px);margin-bottom:-8px}#vdt_hide{margin-bottom:10px}.vdt-flex{display:none}.vdt-svg{fill:var( --color-dove-gray,rgba(0,0,0,.6));height:var(--spacer-twentyfour,24px);width:var(--spacer-twentyfour,24px)} (function() { let vdContainer, vdShow, vdHide, flagCaption = false, vdToggle = document.getElementById('videoDetailsToggle'), section = ga_data.route.sectionName || ga_data.route.ssts.split('/'), subsection = ga_data.route.ssts.split('/'); vdToggle.addEventListener('click', ()=> { // query dom only after user click if (!vdContainer) { vdContainer = document.getElementById('videoDetailsContainer'); vdShow = document.getElementById('vdt_show'), vdHide = document.getElementById('vdt_hide'); } vdContainer.hidden = !(vdContainer.hidden); // show/hide elements if (vdContainer.hidden) { vdShow.hidden = false; vdHide.hidden = true; } else { if (!flagCaption) { flagCaption = true; fireCaptionAnalytics() } vdShow.hidden = true; vdHide.hidden = false; } }); function fireCaptionAnalytics () { let analytics = document.getElementById("pageAnalytics"); try { if (analytics) { analytics.fireEvent(`${ga_data.route.basePageType}|${section}|${subsection}|streamline|expandCaption`); } else { if (window.newrelic) window.newrelic.noticeError('page analytics tag not found'); } } catch (e) { if (window.newrelic) window.newrelic.noticeError(e); } } }()); What is a 'ghost tapping' scam? How thieves steal your moneyCrooks use tap-to-pay technology to target smartphones, getting close enough to steal money before victims realize anything is wrong.Fox - 7 AustinYou’re not alone if you tap to pay without thinking much about it.

Economie

Amazon overhauls its AI strategy, winding down most flagship models - Business Insider

Amazon is overhauling its AI strategy, winding down many in-house models, reorganizing teams, and focusing engineers on a new strategy to compete at the frontier, according to people familiar with the matter. The changes follow layoffs in Amazon's Artificial General Intelligence, or AGI, organization last week and the shutdown of AGI Lab, a research group it created in 2024 after hiring most of the team behind AI startup Adept.

Economie

SpaceX Stock: Why IPO History Prompts A Double-Upgrade (NASDAQ:SPCX) - Seeking Alpha

Stock IdeasLong IdeasCommunication ServicesSpaceX: Why IPO History Prompts A Double UpgradeJul 25, 2026, 10:28 AM ETSpace Exploration Technologies Corp. (SPCX) Stock, SPCX:CA StockMike Zaccardi, CFA, CMT9.5K FollowersFollow5ShareSavePlay(8min)Comments(151)SummarySpaceX is upgraded to a buy after a 51% peak-to-trough decline, aligning with historical IPO drawdown patterns that signal attractive long-term entry points.SPCX now trades 15% below its IPO price; technicals show emerging support at $111, with $102 as a key historical buy zone and $120 as a near-term confirmation level.Despite heavy selling and upcoming share unlocks, I believe the drawdown largely prices in supply risks, with major Wall Street targets (e.g., $300 from Morgan Stanley) remaining bullish.Q2 2026 earnings on August 4 could act as a clearing event, with implied volatility at 115% suggesting a significant price move ahead.

Economie

US regulators to weigh controversial peptides backed by RFK Jr - Al Jazeera

The US Food and Drug Administration has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing. xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoUS Secretary of Health and Human Services Robert F Kennedy Jr listens during a May 27 Cabinet meeting at the White House, in Washington, DC, the United States By Al Jazeera Staff, Reuters and The Associated PressPublished On 22 Jul 202622 Jul 2026Peptides, a class of compounds increasingly marketed as wellness treatments, have exploded in popularity in recent years, moving from niche bodybuilding and biohacking circles to now being promoted for everything from weight loss to longevity.

Acasa Recente Radio Județe